Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries

Am J Cardiol. 2004 Oct 1;94(7):913-7. doi: 10.1016/j.amjcard.2004.06.027.

Abstract

The treatment of bifurcation lesions (BLs) is associated with high procedural complication and restenosis rates. Two techniques of BL interventions were compared: the simultaneous kissing stents (SKS) technique, involving 2 stents, 1 in the main vessel and 1 in the side branch (n = 100), and the conventional stent strategy (CSS) technique, involving a stent in the main vessel and provisional stenting for the side branch (n = 100). In-hospital and 30-day major adverse cardiac events were greater in the CSS group, with significantly less procedure time with the SKS technique. The incidence of target lesion revascularization was 5% in the SKS group and 18% in the CSS group (p = 0.007). Therefore, the SKS technique seems to be rapid, safe, and effective for the treatment of medium- to large-size BLs, with a trend toward fewer acute complications and promising mid-term results.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Abciximab
  • Aged
  • Angioplasty, Balloon, Coronary / methods
  • Antibodies, Monoclonal / therapeutic use
  • Biomarkers / blood
  • Blood Vessel Prosthesis Implantation / methods*
  • Clopidogrel
  • Coated Materials, Biocompatible / therapeutic use
  • Combined Modality Therapy
  • Coronary Angiography
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / therapy*
  • Coronary Vessels / pathology
  • Coronary Vessels / surgery
  • Creatine Kinase / blood
  • Creatine Kinase, MB Form
  • Disease-Free Survival
  • Equipment Design / instrumentation
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Isoenzymes / blood
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction / blood
  • Myocardial Infarction / etiology
  • New York
  • Platelet Aggregation Inhibitors / therapeutic use
  • Postoperative Complications / blood
  • Postoperative Complications / etiology
  • Severity of Illness Index
  • Stents*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Treatment Outcome
  • Troponin I / blood

Substances

  • Antibodies, Monoclonal
  • Biomarkers
  • Coated Materials, Biocompatible
  • Immunoglobulin Fab Fragments
  • Isoenzymes
  • Platelet Aggregation Inhibitors
  • Troponin I
  • Clopidogrel
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Ticlopidine
  • Abciximab